ImmuCell CorporationICCCNASDAQ
Loading
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q4 2025 | 23.14% |
| Q3 2025 | -16.14% |
| Q2 2025 | -15.98% |
| Q1 2025 | 18.45% |
| Q4 2024 | 78.82% |
| Q3 2024 | 28.69% |
| Q2 2024 | -46.39% |
| Q1 2024 | 82.46% |
| Q4 2023 | -0.70% |
| Q3 2023 | 21.36% |
| Q2 2023 | 247.07% |
| Q1 2023 | -80.98% |
| Q4 2022 | -14.35% |
| Q3 2022 | 8.13% |
| Q2 2022 | -44.98% |
| Q1 2022 | 21.19% |
| Q4 2021 | 5.87% |
| Q3 2021 | 16.60% |
| Q2 2021 | 29.47% |
| Q1 2021 | -1.16% |
| Q4 2020 | -5.89% |
| Q3 2020 | 34.23% |
| Q2 2020 | -42.61% |
| Q1 2020 | 21.65% |
| Q4 2019 | 26.65% |
| Q3 2019 | 16.20% |
| Q2 2019 | -43.27% |
| Q1 2019 | 57.70% |
| Q4 2018 | 46.80% |
| Q3 2018 | -36.04% |
| Q2 2018 | 9.35% |
| Q1 2018 | 12.19% |
| Q4 2017 | 29.51% |
| Q3 2017 | 1.57% |
| Q2 2017 | -57.18% |
| Q1 2017 | 76.58% |
| Q4 2016 | 1.16% |
| Q3 2016 | -2.84% |
| Q2 2016 | -29.46% |
| Q1 2016 | 6.04% |